Director of the Institute of Psychiatry and Mental Health and Head of the Child and Adolescent Psychiatry Service of the Hospital General Universitario Gregorio Marañón (chosen as the best Psychiatry Service in 2014, 2015, 2016, 2017, 2018, 2019 and 2020 by the Health Reputation Monitor and by the Index of Hospital Excellence of the Institute of Coordinates), Seal of European Excellence +500 EFQM (first Service to achieve +500 in Spain) and Award for Excellence in Public Management awarded by the Ministry of Finance and Public Administrations, Ibero-American Award of excellence in management.

Doctor of Medicine and Specialist in Legal Psychiatry from the Complutense University of Madrid, and in Clinical Management from the University of Deusto.

Professor of Psychiatry at the Complutense University of Madrid from 2018 to the present; Full Professor of Psychiatry, School of Medicine, University of Maryland, USA from 2013 to the present; Professor of Psychiatry, Department of Psychiatry, The University of California, San Francisco (UCSF), USA from 2015 to the present; Visiting Professor of Psychiatry, Department of Psychosis Studies, King's College London, United Kingdom since 2017.

In the recent COVID-19 pandemic, he has led and coordinated different initiatives at the international level in the response that has been given to it from the Mental Health Services, which has been reflected in magazines such as "The Lancet" or in the publications on mental health and the WHO pandemic.

Editor of 12 books and 46 book chapters.

Author of more than 655 scientific publications indexed in national and international journals (first author in 110 articles, last author in 185 articles and corresponding author in 60, total articles signed priority 355).

Main lines of research: neurodevelopmental disorders, early-onset psychosis and prevention in psychiatry. Main milestones in research: coordinator of the largest international cohort of first psychotic episodes in children and adolescents, coordinator of the first clinical trial comparing two atypical antipsychotics in adolescents, first researcher to transfer the finding of lower antioxidant levels (glutathione) to a clinical trial targeting this mechanism of action (N-acetylcysteine), author of the main studies on genetics in schizophrenia with samples of more than 100,000 subjects, author of the first atlas of risk factors in mental disorders. These works have been published in journals such as Nature, Nature Genetics, Nature Neuroscience, Nature Communications, Nature Medicine, Lancet, PNAS, Journal of Neuroscience, World Psychiatry, Jama Psychiatry, etc.

Total citations received: 24290; Cumulative Impact Factor: 3590.951; Average number of citations per publication: 21.27. H-Index (Scopus): 66, H-Index (Google scholar): 84.

More than 735 communications and presentations at national and international congresses between the years 1993-2021.

Professor in 2 undergraduate courses and 24 doctoral courses; Director of 19 doctoral theses.

Number of periods of research activity (six-year terms): 4

Participant in more than 76 public and private competitive research projects; 58 as principal investigator. Coordinator of an ISCIII Thematic Network; Coordinator and Scientific Director of the Center for Biomedical Research in the Mental Health Network (CIBERSAM) until 2016 and participant in 13 European projects funded by the European Commission (ten in the VII Framework Program and three in H2020), in eight of them as Principal Investigator. Principal investigator in 3 projects funded by NIH or Wellcome Trust. Coordinator of the Neuroscience and Mental Health area of ​​the Gregorio Marañón Health Research Institute (IISGM).

Member of the Editorial Committee of 19 international scientific journals, reviewer of another 6 journals on psychiatry and schizophrenia and member of 9 National and International Scientific-Professional Societies.

Member of the European Brain Council (advisory body of the European Commission).

Advisor to the EMA and the AEM.

66 Prizes awarded by national and international Scientific Societies, public and private institutions.
Cross of the Civil Order of Health, by Commendation and in the category of Commander, awarded by the Ministry of Health and Consumer Affairs..
President of the European College of Neuropsychopharmacology (ECNP).
Director international course New Frontiers in Digital Health.
President of the Spanish Society of Psychiatry (SEP).
President of the National Commission of the Specialty of Psychiatry of the Ministry of Health.
Member of the Executive Committee of the World Psychiatric Association.
President of the Delegate Commission of Psychiatry of the Ministry of Health.
Member Permanent Commission National Council Specialties in Health Sciences of the Ministry of Health.


Celso Arango